Migraine Headaches

Title:

Description:

Migraine Headaches

Woman with a migraine

  • Episodic Migraines & Employed
  • Episodic Migraines Study #2
Episodic Migraines & Employed

Phase: 4

Ages Eligible for Study:    18 Years to 99 Years

Inclusion Criteria:

  • Documented history of migraine with or without aura for greater than or equal to 12 months
  • Has Episodic Migraines defined as history of greater than or equal to 4 and less than 15 migraine days and less than 15 headache days per month on average during the 3 months prior to initial screening
  • Employed greater than or equal to 20 hours/week upon entry into initial screening and has not specified willful termination of employment throughout the duration of the study. Employment is defined by work outside the home, self-employed, or works from home
  • Has greater than or equal to 4 hours of lost productive time in the past month prior to initial screening
  • History of treatment failure with at least 1 preventive treatment category for migraine

Exclusion Criteria:

  • Older than 50 years of age at migraine onset
  • History of cluster headache, hemiplegic migraine, or other trigeminal autonomic cephalalgia.
  • Taken an opioid and/or opioid-containing analgesic greater than 12 days during the 3 months prior to screening for any indication
  • Taken a butalbital and/or butalbital-containing analgesic greater than 6 days during the 3 months prior to screening for any indication

There are additional criteria to meet in order to qualify for this research study. For more information contact us!

Study Location: Jacksonville

Episodic Migraines Study #2

Phase: 4

Ages Eligible for Study:    18 Years and older

Inclusion Criteria:

  • Documented history of migraine with or without aura for greater than or equal to 12 months.
  • History of treatment failure with at least 1 preventive treatment for migraine. Failure of preventive treatment for migraine is defined as treatment discontinuation due to lack of efficacy, adverse event, or general poor tolerability.

Exclusion Criteria:

  • History of hemiplegic migraine, cluster headache, or other trigeminal autonomic cephalalgia.
  • Has any medical contraindication to the use of an oral triptan.
  • Previously treated with any agent (monoclonal antibody or small molecule) targeting the calcitonin gene-related peptide (CGRP) pathway (ligand or receptor) in the preventive setting.

There are additional criteria to meet in order to qualify for this research study. For more information contact us!

Study Location: Jacksonville


If you have Migraine Headaches, you may qualify for one of our studies.
Qualified volunteers may receive at no cost:
  • investigational medication
  • study-related care from a local doctor
  • possible compensation
Health insurance isn’t required to participate.
Ask your doctor or contact our clinic for more information
(904) 730-0166
Or sign up below!


Migraine research is enrolling at:


Jacksonville Center for Clinical Research
4085 University Blvd., South
Suite 1
Jacksonville, FL 32216
(904) 730-0166



Learn More

If you want us to contact you about our research studies call (904) 730-0166 or sign up below!

Category
Jacksonville
Encore logo

As a proven clinical research organization, we take every precaution to assure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

Copyright 2020 ENCORE Research Group